Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWHIreland Regulatory News (WHI)

  • This share is currently suspended. It was suspended at a price of 3.75
  • There is currently no data for WHI

ESOT Purchases

26 Oct 2021 07:00

RNS Number : 2513Q
W.H. Ireland Group PLC
26 October 2021
 

26 October 2021

 

WH Ireland Group Plc

 

("WH Ireland" or the "Company")

 

ESOT Purchases

The Directors have received notice that on 2 September 2021 the Company's Employee Share Option Trust ("ESOT"), the trustee for which is Sanne Fiduciary Services Limited ("Sanne"), acquired 50,000 Ordinary Shares in the Company (the "ESOT Purchase Shares") at a price of 54.86p per share. Sanne can acquire up to 50,000 Ordinary Shares each month pursuant to the terms of the ESOT Purchase Plan, the details of which are set out in the announcement of 18 May 2021. A monthly share purchase plan is currently in place.

The total number of shares now held by Sanne, as trustee of the ESOT, is 2,379,500 Ordinary Shares representing 3.83% of the total issued share capital of the Company ("ESOT Shares"). 

It is the intention that the ESOT Shares will be used to satisfy the awards of share options granted to employees of the Company (or for such other purposes as may be required of the Trust from time to time).

The notifications set out below are provided in accordance with the requirements of the Market Abuse Regulation.

1

Details of the PCA

a)

Name

Sanne Fiduciary Services Limited, as trustee for the WH Ireland Employee Share Option Trust

2

Reason for the notification

a)

Position/status

PCA of the Directors (as a connected trust)

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

WH Ireland Group plc

b)

LEI

213800HB9TO5O4WD6S66

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.5 pence each

 

GB0009241885

b)

Nature of the transaction

Acquisition of existing shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

54.86p

50,000

d)

Aggregated information

- Aggregated volume

 - Price

 

50,000

54.86p

e)

Date of the transaction

25 October 2021

f)

Place of the transaction

London Stock Exchange (XLON)

 

For further information please contact:

WH Ireland Group plc

www.whirelandplc.com

Phillip Wale, Chief Executive Officer

+44(0) 20 7220 1666

Canaccord Genuity Limited

www.canaccordgenuity.com

Andrew Potts / Tom Diehl

+44(0) 20 7523 8000

MHP Communications

whireland@mhpc.com

Reg Hoare / James Bavister

+44 (0) 20 3128 8793

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKABNPBDKKKB
Date   Source Headline
17th Nov 202512:58 pmRNSForm 8.3 - W.H. Ireland Group PLC
14th Nov 202510:13 amRNSForm 8 (DD)
13th Nov 20259:39 amRNSForm 8.3 - WH Ireland Group plc
13th Nov 20259:37 amRNSDisclosure Table
13th Nov 20258:38 amRNSDisclosure Table
13th Nov 20257:49 amRNSDisclosure Table
13th Nov 20257:00 amRNSPossible Offer
5th Nov 20257:00 amRNSDirectorate Change
29th Oct 20257:00 amRNSDeferred Consideration re Capital Markets Division
27th Oct 20252:51 pmRNSResult of GM
27th Oct 20257:00 amRNSDirectorate Change
20th Oct 20251:49 pmRNSAdjournment of GM
16th Oct 20259:24 amRNSHolding(s) in Company
16th Oct 20259:23 amRNSHolding(s) in Company
9th Oct 20253:07 pmRNSResult of General Meeting
8th Oct 202510:21 amRNSResponse to Press Speculation
30th Sep 20253:23 pmRNSResult of AGM
26th Sep 20254:14 pmRNSFinal Results, Notice of GM and Annual Report
22nd Sep 20257:26 amRNSConditional disposal of Wealth Management Business
5th Sep 20257:00 amRNSNotice of AGM
10th Feb 20257:00 amRNSHenley Office
17th Dec 20241:17 pmRNSHolding(s) in Company
13th Dec 20247:04 amRNSInterim Results
17th Oct 20247:00 amRNSChange of Nominated Adviser and Broker
14th Oct 20247:00 amRNSNominated Adviser Status
30th Sep 20244:08 pmRNSResult of AGM
10th Sep 20249:51 amRNSHolding(s) in Company
30th Aug 202412:00 pmRNSNotice of AGM and Publication of Annual Report
22nd Aug 20245:46 pmRNSHolding(s) in Company
12th Aug 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSCompletion of Sale of the Capital Markets Division
27th Jun 20246:19 pmRNSHolding(s) in Company
27th Jun 20246:17 pmRNSHolding(s) in Company
26th Jun 202410:26 amRNSConfirmation of Chair Appointment
21st Jun 20248:09 amRNSDirector Notification
3rd Jun 20247:00 amRNSSale of Capital Markets Division & Trading Update
20th May 202411:14 amRNSResponse to Press Speculation
27th Dec 20237:00 amRNSInterim Results for Six Months ended 30 Sep 2023
16th Nov 20237:00 amRNSBoard Changes
24th Oct 20232:07 pmRNSResult of AGM
27th Sep 20237:00 amRNSFinal Results and Notice of AGM
23rd Aug 20237:00 amRNSHolding(s) in Company
22nd Aug 202310:08 amRNSHolding(s) in Company
22nd Aug 202310:07 amRNSHolding(s) in Company
21st Aug 20239:26 amRNSHolding(s) in Company
18th Aug 202311:06 amRNSHolding(s) in Company
17th Aug 20235:14 pmRNSHolding(s) in Company
17th Aug 20234:09 pmRNSHolding(s) in Company
17th Aug 20239:16 amRNSHolding(s) in Company
16th Aug 20232:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.